Atlas Trials

Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer

Clinical trial NCT06797622 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06797622
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastatic Breast Cancer
Start date
2025-02-15
Primary completion
2027-01-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.